Third suspect in alleged sale of vaccination slots denies involvement | Inquirer News

Third suspect in alleged sale of vaccination slots denies involvement

By: - Reporter / @zacariansINQ
/ 06:43 PM June 09, 2021

MANILA, Philippines — The third suspect in the alleged scheme involving the sale of vaccination slots has denied her involvement, adding that she was “completely baffled” for being included in the suspect list.

The Philippine National Police (PNP) identified on Wednesday Nina Dizon-Cabrera, founder and CEO of local make-up brand Colourette Cosmetics, as the third suspect in the said scheme in Mandaluyong City.

“I am completely baffled as to why I am being dragged into this scheme when in fact, I exposed this exact scam on my twitter account last May 21, 2021,” said Dizon-Cabrera in a statement posted on Twitter.

Article continues after this advertisement

She was the first to post about the scheme on social media, revealing to the public its existence for the first time.

FEATURED STORIES

Below are Dizon-Cabrera’s tweets on May 21 exposing the said scheme:

According to Dizon-Cabrera, she is already in talks with her lawyer regarding the matter.

“The truth, as always, shall prevail,” the businesswoman said.

According to the PNP, the Anti-Cybercrime Group listed Dizon-Cabrera as a suspect after investigations showed she offered 50 to 100 vaccination slots in Mandaluyong City.

JE
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Nina Cabrera, vaccine sale

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.